Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-14

Clinical Trial Update: Indigo Naturalis in Treating Atopic Dermatitis Topically [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating the safety and efficacy of topical Indigo Naturalis for atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indigo Naturalis (topical) (Indigo naturalis)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED